chrisvoncsefalvay/vaers-outcomes huggingface dataset:
His arm was pretty sore after his 2nd shot.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (His arm was pretty sore after his 2nd shot.) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (His arm was pretty sore after his 2nd shot.). At the time of the report, VACCINATION SITE PAIN (His arm was pretty sore after his 2nd shot.) had resolved.            Concomitant medications was not provided by the reporter. Treatment information was not provided.
Dizziness, brain fog, stiff neck, migraine  head aches, Constant Pressure
10/27/22 I woke up and did not feel good. I was tired, body ached and felt horrible. I felt like I wanted to go right back to sleep. This continued and I did not get better. On 11/15/22 I had an appointment with my doctor. My blood pressure and heart rate were high. I had an echocardiogram and found out my heart was slightly enlarged. I was referred to a pulmonologist. I saw the Pulmonologist at the end of November. I had different fitness tests with my lung and I also had an MRI of my chest at a later time. I also had a sleep study and am on a C-Pap Machine. I still continue to not feel well, feeling tired, body aches all the time. I just want to sleep all the time. This continued. At the beginning of March, I went into Atrial Fibrillation and had a Cardio Version done.
Heavy period on and off since I got the vaccine. Have had three periods since the end of month July. This is unusual for me since I have had a normal period my whole life. I know my body and this is not normal and the only change is the fact that I got vaccinated.
fever, chills on 18APR96 & 19APR96;also exp joint stiffness & pain & post auricular lymphadenopathy;rash on arms & trunk began on 21APR96;
Date of Admission: 10/22/2022.   Date of Discharge: 10/27/2022.   Admission Diagnosis: COVID-19      Hospital Principal Problem (Discharge Diagnoses): 1). Acute COVID-19 infection 2). Superimposed pneumonia 3). HTN 4). Seizure disorder 5). Constipation 6). Hypothyroidism with factitious hyperthyroidism 7). Overactive bladder 8). Nutritional deficiencies 9). Opioid dependence 10). GERD 11). Esophageal massive dilation S/p gastric bypass 12). Neuropathy 13). Deconditioning 14. Hyperkalemia
administered a dose to a 16 year old not knowing the age restriction of 18; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered a dose to a 16 year old not knowing the age restriction of 18) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered a dose to a 16 year old not knowing the age restriction of 18). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered a dose to a 16 year old not knowing the age restriction of 18) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was reported. No concomitant medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: No new information was reported.
woke up fatigued, dizzy, Stayed home from school. on 1/27 mom noticed a lump on his neck on the left side, headache, tired.
Runny nose, some muscle aches on 7/21/22. Positive home COVID test. Reported to family physician's office; declined paxlovid as symptoms are mild.
Dizziness to the point I can?t keep my balance. I get so dizzy I can feel my eyes rolling back. It goes on all day. Has been going on for the past 4 days. Can?t make sudden quick movement or I loose my balance or eyes start rolling back.
Information has been received from the mother of a 12 year old female patient, who on 07-MAY-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast). On 10-JUL-2008, the patient received the second dose of GARDASIL vaccine (yeast). The consumer reported that about three minutes after receiving the second dose of GARDASIL vaccine (yeast), her daughter felt nauseous and fainted. About 15 minutes later she came to and went    home. The consumer reported that when her daughter got home she laid down for about an hour and she was doing better. The consumer also reported that her daughter did eat breakfast that morning before getting GARDASIL vaccine (yeast). The patient sought unspecified medical attention. At the time of the report the patient was recovering. Additional information has been requested.
Moderna Booster vaccine expired 11/9/2021 (prior to administration). No adverse symptoms noted with pt.
pt recvd vax; was unable to walk; dx r/o MI; hx of HTN DM;
8 days after receiving vaccine, a 2-3 inch red, itchy, hot rash appears around the injection site.  There was swelling and pain at the injection site.  16 days after receiving vaccine, burning, itchy mouth.  Tingling of lips when eating certain foods.
Within 10 minutes lips were tingling and small hives on roof of mouth (1635). After 30 minute evaluation I left since I thought it might be anxiety or Placebo. Took 2 Benadryl. At 1830 decided I needed to go to the ER since symptoms were worsening. Tongue  swelling, hives on roof of mouth getting larger in size and increasing surface area, larger hives on inside of mouth, lips noticeably swelling to those who didn?t know me, lips tingling, face itchy and discolored, getting harder to breathe to the point of being painful to swallow and talk.   In the ER they have me a epinephrine shot in my left thigh and a intravenous dose of steroids in right arm. Observed for roughly 2-2.5 hours then sent home. Have a Rx for prednisone (3 20mg tablets for next 5 days) and instructions to contact allergist/ immunologist within 10 days.   To date (12/25) symptoms are: still swollen lips although not as large, itchy face/ neck, sores on inside of mouth, throat still sore but can safely talk and eat without problems.
NO TREATMENT HAS BEEN ADMINISTERED TO THE PATIENT. THE PROVIDER HAS BEEN NOTIFIED
Cough; running nose; tiredness; upset stomach; diarrhea lasted for another 7 days; This is a spontaneous report from a contactable consumer (patient). A 79-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, administrated in Left arm on 28Jul2021 19:30 (age at the time of vaccination 79-years-old), as a single dose and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, administrated in Left arm on 28Jul2021 19:30 (age at the time of vaccination 79-years-old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. No other vaccine in four weeks. No other medications in two weeks. Patient had no known allergies. On 28Jul2021 19:30, the patient experienced Cough, running nose, tiredness, upset stomach, and diarrhea lasted for another 7 days. Patient received cough syrup / aspirin / steam vaporizer as a treatment for adverse events. Patient visited to physician office. No covid prior vaccination. No covid tested post vaccination. The outcome for all the events was recovered on an unspecified date Aug2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Missed or skipped period.  First Day of Last Period was April 1st.  As of today, 5/11/21,  I have not started.  I've taken pregnancy tests that are negative.
approximately 10 minutes after the innoculatioin the patient was sitting and talking with me and thenjust drooped his head down andwas unresponsive.  I shook him and said his name while my coworker called 911.A retired nurse assisted me . As patient was coming  to he tried to stand up and appeared to be convulsing, so we sat him back in the chair. He then wasa responsive but sweating profusely.  We got him to the floor andput cold compresses on forehead and neck and waited for 911 to arrive.  They released him to his girlfriend to bring him home.
Information has been received from a consumer concerning her 9 and 1/2 week old daughter who on 18-JUN-2007 was vaccinated with a dose of Rotateq and immediately threw up. There was no concomitant medication. The patient recovered on 18-JUN-2007. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Information has been received through the manufacturer pregnancy registry from a physician concerning a 25 year old female pt who on 10/22/02 was vaccinated with a dose of varicella virus vaccine live. Her pregnancy test at this time was reported as negative. She has since become pregnant, her LMP was 9/30/02. Unspecified medical attention was sought. On 10/23/03 the physician reported that the pt had a therapeutic abortion. No additional info was provided. No further info is available.
vaccination site pain; Fever; This case was reported by a other health professional via sales rep and described the occurrence of pain in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received in December 2018 and experienced injected site pain refer case US2019AMR071499).   In February 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced pain and fever. On an unknown date, the outcome of the pain was not recovered/not resolved and the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the pain and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but the patient was 63 years old at the time of reporting. It was reported that 2 months after receiving the 1st dose of Shingrix the patient received 2nd dose of Shingrix on right arm. The patient experienced pain and fever for two days. The reporter wondered what treatment the patient could get to overcome the pain.
This spontaneous report as received from a pharmacist refers to a 72 year old male patient with no pertinent medical history and drug reactions or allergies. On 22-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 (lot# K007824 and expiration validated as 05-NOV-2015) (dose/frequency reported as 0.5ml/once), intramuscularly. Concomitant therapies included PLAVIX. The reporter was calling to report that after a patient received the PNEUMOVAX 23 intramuscularly on 22-OCT-2014 the patient developed a "hard bulge under skin" at the injection site while the patient was still at the pharmacy. No diagnostic tests were reported. The patient did not seek medical attention. There was no treatment given for the event. The outcome of "hard bulge under skin at the injection site" was unknown. The relatedness between the event and PNEUMOVAX 23 was not reported. Additional information has been requested.
t105; vomiting next day; 2 days p/vax pt taken to ER w/fever of 105, also had vomiting & diarrhea; fever brought down w/cold bath & APAP & Ibuprofen; 1 wk p/ER visit went to hosp w/diarrhea & resulting dehydration;
Sudden onset hearing loss started 48 hours after injection, ringing in ears, still ongoing two weeks later. Some hearing regained
redness and soreness at the injection site; redness at the injection site; soreness at the injection site; patient received Menactra insted of Tuberculin; Initial information was received on 15-Sep-2020 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 41 years old female patient who received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] instead of TUBERCULIN PPD (TUBERCULIN TEST)(wrong product administered) and experience redness and soreness at the injection site (vaccination site inflammation, vaccination site erythema and vaccination site pain).    Medical history, past medical treatments, past vaccination and family history were not provided.  No other vaccines were administered concomitantly.  On 09-Sep-2020, patient went for TB test and accidently grabbed and administered a 0.1 mL dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [lot U6560BA, expiry date: 02-Apr-2021] once via an intradermal route at the right forearm instead of TUBERCULIN PPD for prophylactic vaccination (wrong product administered- same day latency).  On an unknown date, the patient developed a non-serious redness and soreness at the injection site (vaccination site inflammation with symptom of vaccination site erythema and vaccination site pain) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  No laboratory data was provided.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for redness and soreness at the injection site.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Burning hot tongue & lips, 5 hrs after Flu shot. No problem breathing, no swelling. She took Benadryl. Today, lips & tongue swollen & looks inflammed under tongue a little & reports there was some swelling initial day.
Caller also stated he knows of 2 other people that had a head cold 2 weeks after receiving the vaccine and would like to report that; This is a spontaneous report from a contactable consumer or other non-health care professional via medical information team. This consumer reported similar events for 2 patients. This is 1st of 2 reports. A patient of unspecified age (Approximate symbol) 70 years) and gender received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the reporter stated he knows of 2 other people that had a head cold 2 weeks after receiving the vaccine and would like to report that. Caller also wondering what happened to those 35 hospitalized patients after receiving the vaccine and had abdominal pain and if there had been any reports of death. The case was non-serious. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021214180 Same reporter, Different Patient
Tooth infection; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INFECTION (Tooth infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH INFECTION (Tooth infection). At the time of the report, TOOTH INFECTION (Tooth infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Numbness, throbbing, burning and "prickly" sensation on (L) arm (upper) down to fingertips - after going to bed around 12 am on date of vaccination - same symptoms on date of second vaccine on (R) arm - symptoms did not go away completely - still experiencing numbness and tingling on forearm and fingers and hands off and on.
Extreme tinnitus. seeing  chiropractor For subluxation disturbance or interference in the nervous system,  due to the devastating effects on my health and  well being for the excessive loud ringing.
Administered vaccine more than 6 hours after vial was punctured; A spontaneous report was received from a nurse concerning a 41-year-old, male, patient who received Moderna's COVID-19 vaccine and experienced the event, administered vaccine more than 6 hours after vial was punctured.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 07 Jan 2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 07 Jan 2021, the mRNA-1273 vaccine vial had been punctured at 08:30 AM and then the vaccine was administered to the patient eight hours later at 4:30 PM.  The patient experienced no symptoms in regards to the event. Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided.   The event, administered vaccine more than 6 hours after vial was punctured, was considered resolved on 07 Jan 2021.; Reporter's Comments: This report refers to a case of out of specification product use for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of out of specification product use.
Patient was given 12+ year old dose instead of pediatric booster (5-11 year old booster). No specific reactions reported.
arm was a little sore; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced pain in arm (Verbatim: arm was a little sore). The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to RSV vaccine.   It was unknown if the company considered the pain in arm to be related to RSV vaccine.   Additional Information: GSK receipt date: 17-SEP-2023 and 18-SEP-2023 This case was reported by a patient via interactive digital media. The patient stated that had mine, no side effects, his/her arm was a little sore.  The patient was following physician's recommendation.  The patient stated that one more boaster and a flu shot.  It did not became a zoomie so it must be safe. The follow-up could not be possible as no contact details were available.
Cardiac symptoms including: pains in chest, pain that "travels" (moves around), palpitations, fluttering, dizziness, disorientation, nausea, headaches, feeling low of oxygen (NOT shortness of breath!), heart "hurts", change from normal blood pressure: one was 107/44, another 107/36, changes in memory/mental norms., loss of energy & motivation, change of menstration cycle (heavier & more painful).
a 16 year old patient received a dose of Flublok / no AE; Initial information received on 28-Oct-2019 regarding an unsolicited valid non-serious case received from a non health care professional (office staff).  This case involves a 16 years old male patient who received vaccine of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot: QJAA1911, expiry date: 27-Jun-2020 via intramuscular route in the right deltoid, on 11-Oct-2019.  The patient's past medical history, medical treatments, vaccinations and family history were not provided.  It was an actual medication error due to inappropriate age at vaccine administration.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
pt recv vax 1995 & in 1996 titers revealed lack of seroconversion;
Initial report received from healthcare professional on 17 October 2013. Four pregnant female patients received FLUZONE HD inadvertently (no other information provided). The patients did not have any reported adverse reactions. Documents held by sender: none.
Narrative: COVID infection with hospitalization following COVID vaccine series 02/16/21 COVID vaccine dose #1 03/09/21 COVID vaccine dose #2 04/01/21 Hospitalized for asymptomatic atrial fibrillation with RVR, COVID negative 04/08/21 Discharged from hospital 01/21/22 Admitted to hospital with malaise, viral pneumonia, COVID positive 01/22/22 Discharged from hospital 01/31/22 Brought to ED by ambulance due to generalized weakness, diarrhea, missed hemodialysis x 1 week, COVID positive, admitted to hospital 02/04/22 Discharge from hospital
Fever of 100.4, dizziness, stomach ache, sweating, nausea, diarrhea
Information has been received from a pharmacist concerning a 67 year old female with no known allergies or medical history reported, who on 24-APR-2009 was vaccinated SQ with a 0.65 ml dose of ZOSTAVAX (Merck) (date, dose and lot number unknown). There was not concomitant medication. The pharmacist reported, the patient developed an injection site reaction after receiving a dose of the vaccine (date unspecified). The patient reported that the site got hot and swollen about the size of 50 cents coin. The pharmacist had not seen the patient but he thought that it is chicken pox. The outcome of the patient was not recovered. the patient called the pharmacist for medical attention. Additional information has been requested.
tingling on right side of arm and lips monitored vital signs all WNL,  assessed for signs of stroke none present felt better and left after speaking with MD
This case was reported by a consumer via interactive digital media and described the occurrence of influenza in a female patient who received Flu vaccine for prophylaxis. On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced influenza. On an unknown date, the outcome of the influenza was unknown. It was unknown if the reporter considered the influenza to be related to Flu vaccine. Additional information was received as follows: The age at vaccination was not reported. The patient agreed that the past years, before the reporting date she had got the flu shot and at least 4 to 5 times a year she experienced the flu so bad. She felt like, she was dying. The patient received shingle shot. She said that they were coming out with a new vaccine, the first one was not good enough. She got in a huge family fight over this whooping cough vaccine and would not be permitted to watch a new baby coming into her family unless she received vaccine. The patient guess she would be looking for another babysitter.
Prolonged malaise, low grade fever, 99-100's for 13 days. After getting both MENACTRA and TRUMENBA (Meningitis A and B) vomiting x 12d.